Literature DB >> 10799336

Uncoupling between bone formation and resorption in ovariectomized rats with chronic cadmium exposure.

K Uriu1, I Morimoto, K Kai, Y Okazaki, Y Okada, Y L Qie, N Okimoto, K Kaizu, T Nakamura, S Eto.   

Abstract

Osteoporosis, osteomalacia, and pathological fractures are characteristic features of Itai-Itai disease. The mechanisms of bone damage caused by cadmium (Cd) exposure have not been fully clarified. We investigated skeletal changes in ovariectomized rats with chronic Cd exposure, using bone histomorphometry and mechanical tests. Female Sprague-Dawley rats at the age of 8 weeks were ovariectomized. Eight weeks after ovariectomy, the rats were divided into two groups: Cd-OVX group (n = 15), ovariectomized rats given cadmium chloride (CdCl(2), 0.18 mg/rat) ip three times a week for 28 weeks; Cont-OVX group (n = 10), ovariectomized rats given distilled water alone for 28 weeks. Cd-OVX rats had a significant increase in serum concentration of intact osteocalcine and showed numerical but not significant increase in urinary excretion of deoxypyridinoline despite a significant decrease in glomerular filtration rate to 40% of the value in Cont-OVX rats. Bone mineral content (BMC) and density were significantly decreased in both the lumbar vertebral body and femur of Cd-OVX rats. Ultimate compressive load in the lumbar body and bending load in the midfemur were significantly lower in Cd-OVX rats than in Cont-OVX rats but the differences were not demonstrated when the values were corrected for BMC. Structural moduli in the lumbar vertebral body and the midfemur were not different between the two groups. Cd-OVX rats showed significant decreases in the trabecular bone volume and trabecular number with increased values in the indices of bone formation and resorption in the lumbar vertebral body cancellous bone in comparison with Cont-OVX rats. In the midfemur, Cd-OVX rats had significantly smaller cortical bone area than Cont-OVX rats but the moment of inertia was identical between the two groups. The indices of bone formation and resorption at endocortical surface of the midfemur were significantly increased in Cd-OVX rats over those in Cont-OVX rats, whereas the indices of bone formation at the periosteal surface were not different between the two groups. These data suggested that chronic Cd exposure exacerbated the uncoupling between bone formation and resorption in ovariectomized rats, which resulted in the osteopenia, structural changes of the bone, and decreased mechanical strength in ovariectomized rats with chronic Cd exposure. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10799336     DOI: 10.1006/taap.2000.8908

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  5 in total

Review 1.  Environmental cadmium exposure and osteoporosis: a review.

Authors:  Katherine A James; Jaymie R Meliker
Journal:  Int J Public Health       Date:  2013-07-23       Impact factor: 3.380

2.  Cadmium exposure affects the expression of genes involved in skeletogenesis and stress response in gilthead sea bream larvae.

Authors:  Asma Sassi; Maria José Darias; Khaled Said; Imed Messaoudi; Enric Gisbert
Journal:  Fish Physiol Biochem       Date:  2012-10-05       Impact factor: 2.794

Review 3.  Cadmium osteotoxicity in experimental animals: mechanisms and relationship to human exposures.

Authors:  Maryka H Bhattacharyya
Journal:  Toxicol Appl Pharmacol       Date:  2009-05-20       Impact factor: 4.219

4.  Impact of occupational cadmium exposure on bone in sewage workers.

Authors:  Mona M Taha; Heba Mahdy-Abdallah; Eman M Shahy; Khadiga S Ibrahim; Safaa Elserougy
Journal:  Int J Occup Environ Health       Date:  2018-09-17

5.  Cadmium-induced effects on bone in a population-based study of women.

Authors:  Agneta Akesson; Per Bjellerup; Thomas Lundh; Jonas Lidfeldt; Christina Nerbrand; Göran Samsioe; Staffan Skerfving; Marie Vahter
Journal:  Environ Health Perspect       Date:  2006-06       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.